Drugs / GP2 peptide
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT03014076 | Jan 2008 → Jan 2016 | breast cancer | Cancer Insight, LLC | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT00524277 | Jan 2007 → Dec 2014 | breast cancer | San Antonio Military Medical Center | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GP2 peptide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00524277 ↗ |
| Modality | Peptide | “GP2 peptide vaccine” NCT03014076 ↗ |